愛康醫療(01789.HK)髖關節置換手術導航系統三類醫療器械註冊證獲批
愛康醫療(01789.HK)公布,於周三(21日)獲得國家藥監局批准的髖關節置換手術導航系統三類醫療器械註冊證。
公司是次獲批的髖關節置換手術導航系統由主機、光學導航設備、台車組成。該可視化智能輔助系統(VTS)在手術過程中精準實時呈現植入假體的角度與深度,提高手術的準確性,實現從術前3D手術規劃、到術中可視化追蹤及髖臼假體植入等全流程輔助,提高手術可視度,精準度和便捷度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.